Ibaraki, Japan

Mari Yanagiya

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Alfresa Pharma Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mari Yanagiya. Retrieved from https://idiyas.com/inventor/mari-yanagiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mari Yanagiya: Innovator in Immunoassay Technology

Introduction

Mari Yanagiya is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of immunoassay technology, particularly through her innovative methods that enhance the efficiency of sample testing. Her work is characterized by a focus on utilizing microparticles for immunological assays.

Latest Patents

Yanagiya holds a patent for a method of immunoassaying specimens using the aggregation reaction of microparticles. This patent describes a technique that allows for the assay of samples by employing microparticles that bind to both the analyte and a specific binding substance. This method is particularly advantageous when the analyte has a limited number of specific binding sites, as it eliminates the need for a competitive substance to induce simultaneous competition in the reaction system.

Career Highlights

Mari Yanagiya is currently associated with Alfresa Pharma Corporation, where she continues to develop and refine her innovative techniques in immunoassay technology. Her work has been instrumental in advancing the capabilities of assay kits, making them more accessible and efficient for various applications.

Collaborations

Yanagiya collaborates with esteemed colleagues such as Mutsumi Tanaka and Mieko Kosaka. Their combined expertise contributes to the ongoing development of innovative solutions in the field of immunology.

Conclusion

Mari Yanagiya's contributions to immunoassay technology exemplify her dedication to innovation and improvement in scientific methodologies. Her patent and ongoing work at Alfresa Pharma Corporation highlight her role as a key figure in advancing immunological testing techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…